Cardiome Pharma Report issue

For profit Phase 3 Phase 4
Founded: Vancouver Canada (1986)
Status: Acquired by Correvio (2013) → now Advanz Pharma (2020)

Organization Overview

First Clinical Trial
2003
NCT00063687
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Active Ingredients

Drugs in Phase 4 Trials (2)

amiodarone (cordarone) (2 trials)

vernakalant hydrochloride (12 trials)

Drugs in Phase 3 Trials (1)

oxypurinol (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Atrial Fibrillation (Phase 4)

Atrial Flutter (Phase 3)

Heart Failure (Phase 3)

Recurrence (Phase 2)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 13
  • # of Trial APIs: 3